<--- Back to Details
First PageDocument Content
Dehydration reaction / Hydrogenation / Alcohol / Ethanol / Ether / Ester / Sulfuric acid / Sorbitan / Chemistry / Functional groups / Isosorbide
Date: 2013-07-07 16:18:14
Dehydration reaction
Hydrogenation
Alcohol
Ethanol
Ether
Ester
Sulfuric acid
Sorbitan
Chemistry
Functional groups
Isosorbide

Microsoft Word - ICPB Final Report[removed]_2_.doc

Add to Reading List

Source URL: www.iowacorn.org

Download Document from Source Website

File Size: 1,44 MB

Share Document on Facebook

Similar Documents

Xanthines / Ketones / Pentoxifylline / Vasodilators / TNF inhibitor / Cirrhosis / Piracetam / Triamcinolone acetonide / Isosorbide mononitrate / Chemistry / Medicine / Organic chemistry

mylan pentoxifylline, heraclene pentoxifylline pentoxifylline piracetam combination tia peyronie pentoxifylline. veterinary use of pentoxifylline pentoxifylline side effect burning urination, pill identity pentoxifylline

DocID: 1gmny - View Document

Population genetics / Kinship and descent / Social inequality / Race / Genetic genealogy / Isosorbide dinitrate/hydralazine / Social interpretations of race / Health equity / Historical race concepts / Medicine / Biology / Health

POLICY FORUM MEDICINE Race and Reification in Science Troy Duster

DocID: 1fN3D - View Document

Heart Failure in the African-American Patient: A-HeFT and the Use of BiDil® (isosorbide dinitrate/hydralazine HCl) BP00202-07

DocID: 1e8MT - View Document

Isosorbide dinitrate/hydralazine / Vasodilators / Tuskegee University / Tuskegee syphilis experiment / Race and health / Tuskegee /  Alabama / Susan Mokotoff Reverby / Food and Drug Administration / Syphilis / Medicine / Health / United States Public Health Service

“Special Treatment”: BiDil, Tuskegee, and the Logic of Race Susan M. Reverby

DocID: 18Nav - View Document

Chemistry / Alendronic acid / Bisphosphonate / Osteoporosis / Hypercalcaemia / Uveitis / Etidronic acid / Pamidronic acid / Isosorbide mononitrate / Bisphosphonates / Medicine / Health

Kwartaalbericht 4e kwartaalfebruari 2003 Contents

DocID: 15OO9 - View Document